Poloxamer 407-induced atherogenesis in the C57BL/6 mouse

Atherosclerosis

Volumn 136, Issue 1, 1998, Pages 115-123

  Palmer, Warren K ^a   Emeson, Eugene E ^b   Johnston, Thomas P ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Aortic lesions; Cholesterol; Cholesterol diet; Cholic acid; Hyperlipidemia; Triglyceride

Indexed keywords

CHOLESTEROL; CHOLIC ACID; POLOXAMER; TRIACYLGLYCEROL;

ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; DIETARY INTAKE; DISEASE PREDISPOSITION; FAT INTAKE; FEMALE; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AORTA; ARTERIOSCLEROSIS; CHOLESTEROL; CHOLESTEROL, DIETARY; FEMALE; HYPERLIPIDEMIAS; LIVER; MICE; MICE, INBRED C57BL; POLOXALENE; RATS; TRIGLYCERIDES;

EID: 0031851403     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00193-7     Document Type: Article

References (33)

1. Shepherd J., Packard C.J. Pharmacological approaches to the modulation of plasma cholesterol. Trends Pharmacol Sci. 9:1988;326.
2. Kritchevsky D. Animal models for atherosclerotic research. In: Kritchevsky D, editor. Handbook of Experimental Pharmacology; Hypolipidemic Agents. New York: Springer, 1975:215.
3. VanLenten BJ. Animal models: the Wantanabe heritable hyperlipidemic rabbit. In: Lusts A, Sparkes S, editors. Genetic Factors in Atherosclerosis: Approaches and Model Systems, Basel: Karger, 1989:125.
4. Rapacz J, Hasler-Rapacz J. Animal models: the pig. In: Lusts A, Sparkes S, editors. Genetic Factors in Atherosclerosis: Approaches and Model Systems. Basel: Karger, 1989:139.
5. Paigen B., Marrow A., Holmes P., Mitchell D., Williams R. Quantitative assessment of atherosclerotic lesions in the mouse. Atherosclerosis. 68:1987;231.
6. Ishida BY, Paigen B. Atherosclerosis in the mouse. In: Lusts A, Sparkes S, editors. Genetic Factors in Atherosclerosis: Approaches and Model Systems. Basel: Karger, 1989:189.
7. Oda H., Matsushita N., Hirabayashi, Yoshida A. Hyperlipoproteinemia in rats fed polychlorinated biphenyls. J Nutr Sci Vitaminol. 36:1990;117.
8. Fraser R., Clark S., Day W., Murry F. Nicotine decreases porosity of the rat liver sieve: a possible mechanism for hypercholesterolemia. Br J Exp Pathol. 69:1988;345.
9. Gustafson S., Vahlquist C., Sjoblom L., Eklund A., Vahlquist A. Metabolism of very low density lipoproteins in rats with isotretinoin (13-cis retinoic acid)-induced hyperlipidemia. J Lipid Res. 31:1990;183.
10. Chajek-Shaul T., Friedman G., Stein O., Shiloni E., Etienne J., Stein Y. Mechanism of the hypertriglyceridemia induced by tumor necrosis factor administration to rats. Biochim Biophys Acta. 1001:1989;316.
11. Ohgochi S., Ichimya H., Yagi A., Hayashi H., Sakamoto N. Copper induced hypercholesterolemia in golden hamsters: enhanced synthesis of cholesterol in livers. Gastroenterol Jpn. 23:1988;629.
12. Cho B., Smith T., Park J., Kummerow F. Effects of estrogen-induced hyperlipidemia on the erythrocyte membranes in chicks. Lipids. 23:1988;853.
13. Garcia-Saniz J., Juarez-Ayala J., Valles V. Pertussis toxin induces fatty liver, hyperlipidemia and ketosis in hamsters. Toxicon. 25:1987;603.
14. 2 receptor agonists in rats. Agents Actions. 20:1987;255.
15. Laurman W., Wronska-Nofer T. Serum lipid and lipoprotein-cholesterol in rats jointly exposed to carbon disulfide and ethanol. Med Proc. 37:1986;337.
16. Goldfarb S. Rapid increase in hepatic HMG CoA reductase activity and in vivo cholesterol synthesis after Triton WR 1339 injection. J Lipid Res. 19:1978;489.
17. Kuroda M., Tanzawa K., Tsujita Y., Endo A. Mechanism for elevation of hepatic cholesterol synthesis and serum cholesterol levels in Triton WR-1339-induced hyperlipidemia. Biochem Biophys Acta. 489:1977;119.
18. Wout Z., Pec A., Maggiore J., Williams R., Palicharla P., Johnston T.P. Poloxamer 407-mediated changes in plasma cholesterol and triglycerides following intraperitoneal injections of rats. J Parenter Sci Technol. 46:1992;192.
19. Schmolka IR. Poloxamers in the pharmaceutical industry. In: Tarcha PJ, editor. Polymers and Controlled Drug Delivery. Boca Raton, FL: CRC Press, 1991:189.
20. Bucolo G., David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 19:1973;476.
21. Allain C.A., Poor L.S., Chan C.S., Richmond W., Fu P.C. Enzymatic determination of total serum cholesterol. Clin Chem. 20:1974;470.
22. Entenman C. General procedures for separating lipid components of tissue. Methods enzymol. 3:1957;301.
23. Emeson E.E., Shen M.L. Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A. Am J Pathol. 142:1993;1906.
24. Steel RGD, Torrie JH. Principles and Procedures of Statistics. New York: McGraw-Hill, 1960.
25. Abe T., Sasaki M., Nakaiima H., Ogita M., Naitou H., Nagase A., Taguchi K., Miyazaki S. Evaluation of pluronic F-127 as a base for the gradual release of anti-cancer drugs. Gan To Kaoaku Ryoko. 17:1990;1546.
26. Nash V.J., Johnston T.P., Palmer W.K. Effects of nicotinic acid on poloxamer 407-induced hyperlipidemia. Pharmacotherapy. 16:1996;10.
27. Porter J.A., Carter B.L., Johnston T.P., Palmer W.K. Effects of pravastatin on plasma lipid concentrations in poloxamer 407-induced hyperlipidemic rats. Pharmacotherapy. 15:1995;92.
28. Devland S., Drisko J., Graf L., Machleder D., Lusis A.J., Davis R.A. Effect of dietary cholesterol and taurocholate on cholesterol 7-α-hydroxylase and hepatic LDL receptors in inbred mice. J Lipid Res. 34:1993;923.
29. Breslow J.B. Mouse models of atherosclerosis. Science. 272:1996;685.
30. Reddick R.L., Zhang S.H., Maeda H. Atherosclerosis in mice lacking apo E. Arterioscler Thromb. 14:1994;141.
31. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., Ross R. Apo E-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 14:1994;133.
32. Johnston T.P., Palmer W.K. Mechanism of poloxamer 407-induced hypertriglyceridemia in the rat. Biochem Pharmacol. 46:1993;1037.
33. Johnston TP, Palmer WK. Effect of poloxamer 407 on the activity of microsomal 3-hydroxy-3-methylglutaryl CoA reductase in rats. J Cardiovasc Pharmacol 1997;29:580.